Hepatitis C

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/52

encourage image

There's no tags or description

Looks like no tags are added yet.

53 Terms

1
New cards

A viral infection of the liver that is blood-borne

What type of infection is Hepatitis C?

2
New cards

Contact with infected blood

- Needle use

- Blood transfusion (prior to 1990)

- Mother to child (vertical transmission)

How is Hepatitis C transmitted?

3
New cards

1. Fibrosis: presence of scar tissue

2. Cirrhosis: functional decline

3. Malignancy: tumor formation

What are the 3 stages of gradual liver dysfunction?

4
New cards

Six major genotypes (general) with numerous subgroups or phenotypes (specific)

How many genotypes of Hepatitis C exist?

5
New cards

1. GI: nausea, anorexia, grey stool, abdominal pain

2. Muscles and joints: myalgia, arthralgia

3. Mental symptoms: depression and fatigue

4. Visual symptoms: jaundice, icterus

5. Dark urine

Clinical manifestations of HCV

6
New cards

1. HepC antibody test

2. Qualitative HCV RNA test

3. Quantitative HCV RNA test/viral load

Additional tests:

- Genotype testing

- Liver biopsy (F0-F4)

- LFTs: ALT, AST, GGT

Diagnosis of HCV

7
New cards

1b

What is the most prevalent genotype/phenotype of HCV?

8
New cards

RIG-I

"alarm system"

Pathogen recognition receptor inside immune cells that detects viral RNA, including HCV RNA (HCV-1)

9
New cards

IPS-1

When RIG-I binds to HCV RNA, it activates a signaling pathway that increases ____, leading to the release of interferons

10
New cards

INF alpha and beta

Cytokines that signal innate cellular defense against HCV (T cells, B cells, NK cells)

- Controls HCV replication

11
New cards

NS3/4A

HCV produces a protease enzyme, ____, that cleaves IPS-1, cutting off the RIG-I pathway

- This helps the virus evade immune detection and persist in the liver

12
New cards

non-structural (NS3, NS4A, NS5A, NS5B)

HCV uses its ____ proteins to replicate its RNA inside liver cells.

13
New cards

HCV attaches to hepatocytes by binding to lipoproteins such as LDL and VLDL, which interact with lipoprotein receptors on the cell surface, allowing HCV to enter the cell.

How does HCV enter hepatocytes?

14
New cards

Risk of Hepatitis B virus (HBV) reactivation in patients coinfected with HBV and HCV, which can cause severe hepatitis or liver failure.

- Patients should be screened and monitored for HBV before and during treatment

What is the black box warning associated with Hepatitis C direct-acting antivirals (DAAs)?

15
New cards

Pegylated interferon (Pegasys, Peg-Intron) combined with Ribavirin

What drugs were used in the traditional treatment of Hepatitis C before DAAs?

16
New cards

They bind to interferon receptors to induce an immune response against HCV.

What is the mechanism of interferons in Hepatitis C treatment?

17
New cards

50%

What was the approximate cure rate for interferon plus ribavirin therapy?

18
New cards

Victrelis (Boceprevir)

Incivek (Telaprevir)

What drugs are examples of 1st generation protease inhibitors (DAAs) for Hepatitis C?

19
New cards

Bind to the NS3/4A protease enzyme to inhibit viral RNA replication.

MOA for Protease Inhibitors

20
New cards

They disrupt viral RNA replication by directly inhibiting specific viral enzymes

What is the mechanism of action of direct-acting antivirals (DAAs) used to treat Hepatitis C?

21
New cards

- NS3/4A protease inhibitors

- NS5A protein inhibitors

- NS5B polymerase inhibitors

What are the main RNA replication enzymes targeted by DAAs?

22
New cards

It cleaves viral polyproteins to produce functional viral components; blocking it prevents replication

What is the function of the NS3/4A protease enzyme in HCV replication?

23
New cards

It is essential for viral RNA replication and assembly of new viral particles.

What is the function of the NS5A protein in HCV?

24
New cards

It functions as the RNA-dependent RNA polymerase, responsible for synthesizing new viral RNA strands

What is the role of the NS5B polymerase in Hepatitis C?

25
New cards

Reactivation of Hepatitis B virus (HBV) in coinfected patients.

What serious adverse event carries a black box warning for DAA therapy?

26
New cards

Sustained virologic response (SVR)

- viral suppression is considered a "cure"

Represents an undetectable HCV RNA using a highly sensitive assay 24 weeks, following the end of treatment.

27
New cards

all 6

Which HCV genotypes can be treated with Epclusa (Sofosbuvir/Velpatasvir)?

28
New cards

1, 4-6

(all but 2 and 3)

Which HCV genotypes are treated by Harvoni (Ledipasvir/Sofosbuvir)?

29
New cards

1-4

(all but 5 and 6)

Which HCV genotypes are treated by Sovaldi (Sofosbuvir)?

30
New cards

1 and 4

Which HCV genotypes are treated by Zepatier (Grazoprevir/Elbasvir)?

31
New cards

4 only

Which HCV genotypes are treated by Technivie (Ombitasvir/Paritaprevir/Ritonavir)?

32
New cards

1 and 3 only

Which HCV genotypes are treated by Daklinza (Daclatasvir)?

33
New cards

1 only

Which HCV genotypes are treated by Viekira (Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir)?

34
New cards

1 only

Which HCV genotype is treated by Olysio (Simeprevir)?

35
New cards

all (1-6)

- used for initial treatment, but also salvage therapy for all genotypes

Which HCV genotypes are treated by Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)?

36
New cards

all (1-6)

- used for initial treatment; may be used as salvage therapy for genotype 1

Which HCV genotypes are treated by Mavyret (Glecaprevir/Pibrentasvir)?

37
New cards

1. Epclusa (Sofosbuvir/Velpatasvir)

2. Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)

3. Mavyret (Glecapravir/Pibrentasvir)

Which 3 regimens are pangenotypic?

38
New cards

1. Uprifosbuvir: NS5B inhibitor

2. Grazoprevir: NS3/4A PI

3. Ruzasvir: NS5A inhibitor

What three drugs make up the investigational triple-combination DAA regimen currently in Phase II trials for genotypes 1-3?

- intended to be once-daily fixed dose

39
New cards

Sovaprevir (ACH-1625)

NS3/4A protease inhibitor currently under investigation that was given fast track status by the FDA during development; candidate for inclusion in combination regimens targeting multiple viral proteins to avoid resistance

40
New cards

12 weeks

What is the recommended duration of DAA therapy for treatment-naïve patients?

41
New cards

add Ribavirin to therapy

What is added to therapy for treatment-experienced or cirrhotic HCV patients?

42
New cards

CD4>200 cells/mm3

Before starting HCV treatment, what CD4 count should HIV coinfected patients have?

43
New cards

HIV treatment may be deferred until HCV treatment is completed.

If an HIV/HCV coinfected patient has a CD4 count > 500 cells/mm³, what is the guideline regarding HIV treatment timing?

44
New cards

1. Zepatier (12-16 weeks)

2. Harvoni (12 weeks)

3. Viekira (12 weeks)

4. Sovaldi + Olysio (12 weeks)

5. Epclusa (12 weeks)

6. Daklinza + Sovaldi (12 weeks)

For a treatment-naïve, genotype 1 patient without cirrhosis, what DAA regimens are options?

45
New cards

1. Zepatier (12 weeks) + Ribavirin

2. Harvoni (12 weeks) + Ribavirin

3. Epclusa (12 weeks) + Ribavirin

For a treatment-naïve, genotype 1 patient with compensated cirrhosis, which regimens are recommended with ribavirin?

46
New cards

1. Mavyret (12 weeks)

2. Vosevi (12 weeks)

For a treatment-naïve, genotype 1 patient with compensated cirrhosis, which regimens are recommended without ribavirin?

47
New cards

1. HBsAg (surface antigen)

2. anti-HBs (surface antibody)

3. anti-HBc (core antibody/antigen)

What laboratory markers should be monitored for HBV spread in coinfected patients?

48
New cards

Pegylated interferon 180 mcg/week

Which medication can treat both HCV and HBV in coinfected patients?

49
New cards

true

T/F: HCV/HIV co-infected individuals are treated and retreated the same as people who have HCV without HIV

50
New cards

Harvoni (Ledipasvir/Sofosbuvir) 1 tablet PO QD x 12 weeks

First oral once daily regimen for HCV; NS5A/5B inhibitor for genotypes 1, 4, 5, 6

- If treatment-experienced or post-liver transplant, co-administer with Ribavirin

51
New cards

1. SVR

- Pre-treatment (baseline)

- Post-treatment: weeks 4, 12, 24

2. Kidney function: SCr, GFR

3. Liver function: LFTs

Monitoring parameters for HCV treatment

52
New cards

Weeks 4, 12, and 24

At which time points is post-treatment viral load typically checked?

53
New cards

METAVIR score

A system used to assess the extent of inflammation and fibrosis by histopathological evaluation in a liver biopsy of patients with Hepatitis C. The grade indicates the activity or degree of inflammation, while the stage represents the amount of fibrosis or scarring.